{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:53:24Z","timestamp":1787032404417,"version":"build-2736575974"},"reference-count":171,"publisher":"e-Century Publishing Corporation","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/kmwb5164","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T05:19:27Z","timestamp":1728364767000},"page":"4633-4651","source":"Crossref","is-referenced-by-count":4,"title":["Molecular significance of circRNAs in malignant lymphoproliferative disorders: pathogenesis and novel biomarkers or therapeutic targets"],"prefix":"10.62347","volume":"14","author":[{"given":"Bo-Yang","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","unstructured":"Bhan A, Soleimani M and Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res 2017; 77: 3965-3981.","journal-title":"Cancer Res"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, Hanan M, Wyler E, Perez-Hernandez D, Ramberger E, Shenzis S, Samson M, Dittmar G, Landthaler M, Chekulaeva M, Rajewsky N and Kadener S. Translation of circRNAs. Mol Cell 2017; 66: 9-21, e27.","DOI":"10.1016\/j.molcel.2017.02.021"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C, le Noble F and Rajewsky N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495: 333-338.","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F and Croce CM. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002; 99: 15524-15529.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1002\/jcp.30200","article-title":"Circular RNAs: rising stars in lipid metabolism and lipid disorders","volume":"236","author":"Yu","year":"2021","unstructured":"Yu G, Yang Z, Peng T and Lv Y. Circular RNAs: rising stars in lipid metabolism and lipid disorders. J Cell Physiol 2021; 236: 4797-4806.","journal-title":"J Cell Physiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13045-020-00976-1","article-title":"The functions and clinical significance of circRNAs in hematological malignancies","volume":"13","author":"Zhou","year":"2020","unstructured":"Zhou X, Zhan L, Huang K and Wang X. The functions and clinical significance of circRNAs in hematological malignancies. J Hematol Oncol 2020; 13: 138.","journal-title":"J Hematol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11357-019-00120-z","article-title":"circRNAs expressed in human peripheral blood are associated with human aging phenotypes, cellular senescence and mouse lifespan","volume":"42","author":"Haque","year":"2020","unstructured":"Haque S, Ames RM, Moore K, Pilling LC, Peters LL, Bandinelli S, Ferrucci L and Harries LW. circRNAs expressed in human peripheral blood are associated with human aging phenotypes, cellular senescence and mouse lifespan. Geroscience 2020; 42: 183-199.","journal-title":"Geroscience"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-981-13-1426-1_11","article-title":"Circular RNA in saliva","volume":"1087","author":"Jafari Ghods","year":"2018","unstructured":"Jafari Ghods F. Circular RNA in saliva. Adv Exp Med Biol 2018; 1087: 131-139.","journal-title":"Adv Exp Med Biol"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Salzman J, Gawad C, Wang PL, Lacayo N and Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One 2012; 7: e30733.","DOI":"10.1371\/journal.pone.0030733"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cell.2014.09.005","article-title":"Biogenesis of circular RNAs","volume":"159","author":"Vicens","year":"2014","unstructured":"Vicens Q and Westhof E. Biogenesis of circular RNAs. Cell 2014; 159: 13-14.","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41569-019-0185-2","article-title":"Circular RNAs open a new chapter in cardiovascular biology","volume":"16","author":"Aufiero","year":"2019","unstructured":"Aufiero S, Reckman YJ, Pinto YM and Creemers EE. Circular RNAs open a new chapter in cardiovascular biology. Nat Rev Cardiol 2019; 16: 503-514.","journal-title":"Nat Rev Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1096\/fasebj.7.1.7678559","article-title":"Mis-splicing yields circular RNA molecules","volume":"7","author":"Cocquerelle","year":"1993","unstructured":"Cocquerelle C, Mascrez B, Hétuin D and Bailleul B. Mis-splicing yields circular RNA molecules. FASEB J 1993; 7: 155-160.","journal-title":"FASEB J"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Wilusz JE. A 360° view of circular RNAs: from biogenesis to functions. Wiley Interdiscip Rev RNA 2018; 9: e1478.","DOI":"10.1002\/wrna.1478"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF and Sharpless NE. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013; 19: 141-157.","journal-title":"RNA"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","article-title":"CircRNA: functions and properties of a novel potential biomarker for cancer","volume":"16","author":"Meng","year":"2017","unstructured":"Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P and Wu M. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer 2017; 16: 94.","journal-title":"Mol Cancer"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","unstructured":"Chen LL and Yang L. Regulation of circRNA biogenesis. RNA Biol 2015; 12: 381-388.","journal-title":"RNA Biol"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A and Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res 2006; 34: e63.","DOI":"10.1093\/nar\/gkl151"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/emboj.2013.53","article-title":"Circular RNAs: splicing’s enigma variations","volume":"32","author":"Hentze","year":"2013","unstructured":"Hentze MW and Preiss T. Circular RNAs: splicing’s enigma variations. EMBO J 2013; 32: 923-925.","journal-title":"EMBO J"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","article-title":"Complementary sequence-mediated exon circularization","volume":"159","author":"Zhang","year":"2014","unstructured":"Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL and Yang L. Complementary sequence-mediated exon circularization. Cell 2014; 159: 134-147.","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","article-title":"Exon-intron circular RNAs regulate transcription in the nucleus","volume":"22","author":"Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, Zhu P, Chang Z, Wu Q, Zhao Y, Jia Y, Xu P, Liu H and Shan G. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol 2015; 22: 256-264.","journal-title":"Nat Struct Mol Biol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs","volume":"51","author":"Zhang","year":"2013","unstructured":"Zhang Y, Zhang XO, Chen T, Xiang JF, Yin QF, Xing YH, Zhu S, Yang L and Chen LL. Circular intronic long noncoding RNAs. Mol Cell 2013; 51: 792-806.","journal-title":"Mol Cell"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cell.2016.07.035","article-title":"Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations","volume":"166","author":"Guarnerio","year":"2016","unstructured":"Guarnerio J, Bezzi M, Jeong JC, Paffenholz SV, Berry K, Naldini MM, Lo-Coco F, Tay Y, Beck AH and Pandolfi PP. Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations. Cell 2016; 166: 1055-1056.","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Bonizzato A, Gaffo E, Te Kronnie G and Bortoluzzi S. CircRNAs in hematopoiesis and hematological malignancies. Blood Cancer J 2016; 6: e483.","DOI":"10.1038\/bcj.2016.81"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2147\/OTT.S371629","article-title":"Circular RNA controls tumor occurrence and development via cell cycle regulation","volume":"15","author":"Liu","year":"2022","unstructured":"Liu F, Qu R, Yang L, Shi G, Hao S and Hu C. Circular RNA controls tumor occurrence and development via cell cycle regulation. Onco Targets Ther 2022; 15: 993-1009.","journal-title":"Onco Targets Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/jb\/mvaa119","article-title":"CircRNA_0092516 regulates chondrocyte proliferation and apoptosis in osteoarthritis through the miR-337-3p\/PTEN axis","volume":"169","author":"Huang","year":"2021","unstructured":"Huang Z, Ma W, Xiao J, Dai X and Ling W. CircRNA_0092516 regulates chondrocyte proliferation and apoptosis in osteoarthritis through the miR-337-3p\/PTEN axis. J Biochem 2021; 169: 467-475.","journal-title":"J Biochem"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jnr.24356","article-title":"The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function","volume":"98","author":"Zang","year":"2020","unstructured":"Zang J, Lu D and Xu A. The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function. J Neurosci Res 2020; 98: 87-97.","journal-title":"J Neurosci Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1038\/s41467-019-12651-2","article-title":"N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis","volume":"10","author":"Chen","year":"2019","unstructured":"Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, Han K, Chen JW, Judde JG, Deas O, Wang F, Ma NF, Guan X, Yun JP, Wang FW, Xu RH and Dan Xie. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun 2019; 10: 4695.","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.7536344","article-title":"Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs","volume":"268","author":"Chen","year":"1995","unstructured":"Chen CY and Sarnow P. Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science 1995; 268: 415-417.","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","article-title":"Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis","volume":"25","author":"Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X and Huang S. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 2015; 25: 981-984.","journal-title":"Cell Res"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Lin H, Yu J, Gu X, Ge S and Fan X. Novel insights into exosomal circular RNAs: redefining intercellular communication in cancer biology. Clin Transl Med 2021; 11: e636.","DOI":"10.1002\/ctm2.636"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6218353","DOI":"10.1155\/2017\/6218353","article-title":"Circular RNAs: biogenesis, function, and a role as possible cancer biomarkers","volume":"2017","author":"Bolha","year":"2017","unstructured":"Bolha L, Ravnik-Glavač M and Glavač D. Circular RNAs: biogenesis, function, and a role as possible cancer biomarkers. Int J Genomics 2017; 2017: 6218353.","journal-title":"Int J Genomics"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Mattick JS and Makunin IV. Non-coding RNA. Hum Mol Genet 2006; 15 Spec No 1: R17-29.","DOI":"10.1093\/hmg\/ddl046"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"118770","DOI":"10.1016\/j.bbamcr.2020.118770","article-title":"GSK-3 and miRs: master regulators of therapeutic sensitivity of cancer cells","volume":"1867","author":"Duda","year":"2020","unstructured":"Duda P, Akula SM, Abrams SL, Steelman LS, Gizak A, Rakus D and McCubrey JA. GSK-3 and miRs: master regulators of therapeutic sensitivity of cancer cells. Biochim Biophys Acta Mol Cell Res 2020; 1867: 118770.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ejca.2014.12.007","article-title":"MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas","volume":"51","author":"Gattolliat","year":"2015","unstructured":"Gattolliat CH, Uguen A, Pesson M, Trillet K, Simon B, Doucet L, Robaszkiewicz M and Corcos L. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer 2015; 51: 409-420.","journal-title":"Eur J Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","unstructured":"Lee YS and Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009; 4: 199-227.","journal-title":"Annu Rev Pathol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","unstructured":"Carthew RW and Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-655.","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353-358.","DOI":"10.1016\/j.cell.2011.07.014"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrg.2016.20","article-title":"Endogenous microRNA sponges: evidence and controversy","volume":"17","author":"Thomson","year":"2016","unstructured":"Thomson DW and Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 2016; 17: 272-283.","journal-title":"Nat Rev Genet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK and Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495: 384-388.","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13046-017-0624-z","article-title":"Circular RNAs: emerging cancer biomarkers and targets","volume":"36","author":"Zhang","year":"2017","unstructured":"Zhang Y, Liang W, Zhang P, Chen J, Qian H, Zhang X and Xu W. Circular RNAs: emerging cancer biomarkers and targets. J Exp Clin Cancer Res 2017; 36: 152.","journal-title":"J Exp Clin Cancer Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12943-021-01390-y","article-title":"CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability","volume":"20","author":"Zhang","year":"2021","unstructured":"Zhang Y, Jiang J, Zhang J, Shen H, Wang M, Guo Z, Zang X, Shi H, Gao J, Cai H, Fang X, Qian H, Xu W and Zhang X. CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol Cancer 2021; 20: 101.","journal-title":"Mol Cancer"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-018-1593-5","article-title":"A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma","volume":"16","author":"Xiong","year":"2018","unstructured":"Xiong DD, Dang YW, Lin P, Wen DY, He RQ, Luo DZ, Feng ZB and Chen G. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med 2018; 16: 220.","journal-title":"J Transl Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pharmthera.2018.01.010","article-title":"Circular RNA and its mechanisms in disease: from the bench to the clinic","volume":"187","author":"Han","year":"2018","unstructured":"Han B, Chao J and Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther 2018; 187: 31-44.","journal-title":"Pharmacol Ther"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"109874","DOI":"10.1016\/j.biopha.2020.109874","article-title":"Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p\/RAP2C axis","volume":"125","author":"Wang","year":"2020","unstructured":"Wang Z, Huang C, Zhang A, Lu C and Liu L. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p\/RAP2C axis. Biomed Pharmacother 2020; 125: 109874.","journal-title":"Biomed Pharmacother"},{"key":"ref44","unstructured":"Zhu LS, Wang YL, Li R, Xu XT, Li KY and Zuo CR. circ_BICD2 acts as a ceRNA to promote tumor progression and Warburg effect in oral squamous cell carcinoma by sponging miR-107 to enhance HK2. Am J Transl Res 2020; 12: 3489-3500."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"110219","DOI":"10.1016\/j.biopha.2020.110219","article-title":"Overexpressed circ-RPL15 predicts poor survival and promotes the progression of gastric cancer via regulating miR-502-3p\/OLFM4\/STAT3 pathway","volume":"127","author":"Li","year":"2020","unstructured":"Li Y, Gong Y, Ma J and Gong X. Overexpressed circ-RPL15 predicts poor survival and promotes the progression of gastric cancer via regulating miR-502-3p\/OLFM4\/STAT3 pathway. Biomed Pharmacother 2020; 127: 110219.","journal-title":"Biomed Pharmacother"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.2147\/OTT.S255485","article-title":"Hsa_circ_0001806 acts as a ceRNA to facilitate the stemness of colorectal cancer cells by increasing COL1A1","volume":"13","author":"Sun","year":"2020","unstructured":"Sun J, Liu J, Zhu Q, Xu F, Kang L and Shi X. Hsa_circ_0001806 acts as a ceRNA to facilitate the stemness of colorectal cancer cells by increasing COL1A1. Onco Targets Ther 2020; 13: 6315-6327.","journal-title":"Onco Targets Ther"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"117255","DOI":"10.1016\/j.lfs.2020.117255","article-title":"Circ_0009910 promotes imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia","volume":"243","author":"Cao","year":"2020","unstructured":"Cao HX, Miao CF, Sang LN, Huang YM, Zhang R, Sun L and Jiang ZX. Circ_0009910 promotes imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia. Life Sci 2020; 243: 117255.","journal-title":"Life Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1089\/ars.2017.7326","article-title":"Hematopoietic stem cells: normal versus malignant","volume":"29","author":"Carroll","year":"2018","unstructured":"Carroll D and St Clair DK. Hematopoietic stem cells: normal versus malignant. Antioxid Redox Signal 2018; 29: 1612-1632.","journal-title":"Antioxid Redox Signal"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.stem.2018.04.015","article-title":"Blood development: hematopoietic stem cell dependence and independence","volume":"22","author":"Dzierzak","year":"2018","unstructured":"Dzierzak E and Bigas A. Blood development: hematopoietic stem cell dependence and independence. Cell Stem Cell 2018; 22: 639-651.","journal-title":"Cell Stem Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0753-3322(01)00051-8","article-title":"Hematopoietic stem cells","volume":"55","author":"Gunsilius","year":"2001","unstructured":"Gunsilius E, Gastl G and Petzer AL. Hematopoietic stem cells. Biomed Pharmacother 2001; 55: 186-194.","journal-title":"Biomed Pharmacother"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nri3044","article-title":"NK cell development, homeostasis and function: parallels with CD8+ T cells","volume":"11","author":"Sun","year":"2011","unstructured":"Sun JC and Lanier LL. NK cell development, homeostasis and function: parallels with CD8+ T cells. Nat Rev Immunol 2011; 11: 645-657.","journal-title":"Nat Rev Immunol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2022.05.001","article-title":"CD4(+) cytotoxic T cells - phenotype, function and transcriptional networks controlling their differentiation pathways","volume":"247","author":"Preglej","year":"2022","unstructured":"Preglej T and Ellmeier W. CD4(+) cytotoxic T cells - phenotype, function and transcriptional networks controlling their differentiation pathways. Immunol Lett 2022; 247: 27-42.","journal-title":"Immunol Lett"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/leu.2016.226","article-title":"Human memory B cells","volume":"30","author":"Seifert","year":"2016","unstructured":"Seifert M and Küppers R. Human memory B cells. Leukemia 2016; 30: 2283-2292.","journal-title":"Leukemia"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.trecan.2017.12.006","article-title":"B-cell metabolic remodeling and cancer","volume":"4","author":"DG","year":"2018","unstructured":"Franchina DG, Grusdat M and Brenner D. B-cell metabolic remodeling and cancer. Trends Cancer 2018; 4: 138-150.","journal-title":"Trends Cancer"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coi.2016.01.007","article-title":"Development and maturation of natural killer cells","volume":"39","author":"Geiger","year":"2016","unstructured":"Geiger TL and Sun JC. Development and maturation of natural killer cells. Curr Opin Immunol 2016; 39: 82-89.","journal-title":"Curr Opin Immunol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"144726","DOI":"10.1016\/j.gene.2020.144726","article-title":"Upregulation of circ-0000745 in acute lymphoblastic leukemia enhanced cell proliferation by activating ERK pathway","volume":"751","author":"Liu","year":"2020","unstructured":"Liu X, Zhou C, Li Y, Deng Y, Lu W and Li J. Upregulation of circ-0000745 in acute lymphoblastic leukemia enhanced cell proliferation by activating ERK pathway. Gene 2020; 751: 144726.","journal-title":"Gene"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1038\/s41598-019-50864-z","article-title":"Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia","volume":"9","author":"Gaffo","year":"2019","unstructured":"Gaffo E, Boldrin E, Dal Molin A, Bresolin S, Bonizzato A, Trentin L, Frasson C, Debatin KM, Meyer LH, Te Kronnie G and Bortoluzzi S. Circular RNA differential expression in blood cell populations and exploration of circRNA deregulation in pediatric acute lymphoblastic leukemia. Sci Rep 2019; 9: 14670.","journal-title":"Sci Rep"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"858","DOI":"10.6004\/jnccn.2012.0089","article-title":"Acute lymphoblastic leukemia","volume":"10","author":"JC","year":"2012","unstructured":"Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, DeAngelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O’Brien S, Petersdorf SH, Rao AV, Terezakis S, Uy G, Wetzler M, Zelenetz AD, Naganuma M and Gregory KM; National Comprehensive Cancer Network. Acute lymphoblastic leukemia. J Natl Compr Canc Netw 2012; 10: 858-914.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/cncr.29383","article-title":"New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia","volume":"121","author":"Jabbour","year":"2015","unstructured":"Jabbour E, O’Brien S, Konopleva M and Kantarjian H. New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer 2015; 121: 2517-2528.","journal-title":"Cancer"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","unstructured":"Inaba H and Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica 2020; 105: 2524-2539.","journal-title":"Haematologica"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/cncr.20668","article-title":"Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"101","author":"Kantarjian","year":"2004","unstructured":"Kantarjian H, Thomas D, O’Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M and Freireich EJ. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 2004; 101: 2788-2801.","journal-title":"Cancer"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.blre.2017.08.006","article-title":"T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies","volume":"32","author":"Vadillo","year":"2018","unstructured":"Vadillo E, Dorantes-Acosta E, Pelayo R and Schnoor M. T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies. Blood Rev 2018; 32: 36-51.","journal-title":"Blood Rev"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3324\/haematol.2008.004150","article-title":"T-cell acute lymphoblastic leukemia","volume":"94","author":"Chiaretti","year":"2009","unstructured":"Chiaretti S and Foà R. T-cell acute lymphoblastic leukemia. Haematologica 2009; 94: 160-162.","journal-title":"Haematologica"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","article-title":"Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial","volume":"14","author":"Vora","year":"2013","unstructured":"Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, Rowntree C and Richards S. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol 2013; 14: 199-209.","journal-title":"Lancet Oncol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","volume":"2016","author":"Raetz","year":"2016","unstructured":"Raetz EA and Teachey DT. T-cell acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2016; 2016: 580-588.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"639910","DOI":"10.3389\/fcell.2021.639910","article-title":"Mechanism of circADD2 as ceRNA in childhood acute lymphoblastic leukemia","volume":"9","author":"Zhu","year":"2021","unstructured":"Zhu Y, Ma X, Zhang H, Wu Y, Kang M, Fang Y and Xue Y. Mechanism of circADD2 as ceRNA in childhood acute lymphoblastic leukemia. Front Cell Dev Biol 2021; 9: 639910.","journal-title":"Front Cell Dev Biol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.leukres.2015.11.016","article-title":"miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia","volume":"41","author":"Fan","year":"2016","unstructured":"Fan SJ, Li HB, Cui G, Kong XL, Sun LL, Zhao YQ, Li YH and Zhou J. miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia. Leuk Res 2016; 41: 62-70.","journal-title":"Leuk Res"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s12010-017-2657-3","article-title":"Triangle of AKT2, miRNA, and tumorigenesis in different cancers","volume":"185","author":"Honardoost","year":"2018","unstructured":"Honardoost M and Rad SMAH. Triangle of AKT2, miRNA, and tumorigenesis in different cancers. Appl Biochem Biotechnol 2018; 185: 524-540.","journal-title":"Appl Biochem Biotechnol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12935-021-01884-1","article-title":"Circ_0000745 strengthens the expression of CCND1 by functioning as miR-488 sponge and interacting with HuR binding protein to facilitate the development of oral squamous cell carcinoma","volume":"21","author":"Li","year":"2021","unstructured":"Li K, Fan X, Yan Z, Zhan J, Cao F and Jiang Y. Circ_0000745 strengthens the expression of CCND1 by functioning as miR-488 sponge and interacting with HuR binding protein to facilitate the development of oral squamous cell carcinoma. Cancer Cell Int 2021; 21: 271.","journal-title":"Cancer Cell Int"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/jcp.29045","article-title":"hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion","volume":"235","author":"Jiao","year":"2020","unstructured":"Jiao J, Zhang T, Jiao X, Huang T, Zhao L, Ma D and Cui B. hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion. J Cell Physiol 2020; 235: 1287-1295.","journal-title":"J Cell Physiol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.3748\/wjg.v23.i34.6330","article-title":"Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer","volume":"23","author":"Huang","year":"2017","unstructured":"Huang M, He YR, Liang LC, Huang Q and Zhu ZQ. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer. World J Gastroenterol 2017; 23: 6330-6338.","journal-title":"World J Gastroenterol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/cancers11040513","article-title":"Divergent dynamics and functions of ERK MAP kinase signaling in development, homeostasis and cancer: lessons from fluorescent bioimaging","volume":"11","author":"Muta","year":"2019","unstructured":"Muta Y, Matsuda M and Imajo M. Divergent dynamics and functions of ERK MAP kinase signaling in development, homeostasis and cancer: lessons from fluorescent bioimaging. Cancers (Basel) 2019; 11: 513.","journal-title":"Cancers (Basel)"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/16078454.2021.2008590","article-title":"Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p\/NET1 axis","volume":"27","author":"Yang","year":"2022","unstructured":"Yang X, Li Y, Zhang Y and Liu J. Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p\/NET1 axis. Hematology 2022; 27: 11-22.","journal-title":"Hematology"},{"key":"ref74","unstructured":"Zhang H, Wu B and Wang Y. Molecular mechanism of circVRK1 regulating the proliferation and apoptosis of acute lymphoblastic leukemia KOCL44 cells by targeting miR-4428. Sichuan Da Xue Xue Bao Yi Xue Ban 2024; 55: 872-877."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s13577-021-00504-4","article-title":"Circular RNA circRNA_0000094 sponges microRNA-223-3p and up-regulate F-box and WD repeat domain containing 7 to restrain T cell acute lymphoblastic leukemia progression","volume":"34","author":"Hou","year":"2021","unstructured":"Hou Y, Sun J, Huang J, Yao F, Chen X, Zhu B and Zhao D. Circular RNA circRNA_0000094 sponges microRNA-223-3p and up-regulate F-box and WD repeat domain containing 7 to restrain T cell acute lymphoblastic leukemia progression. Hum Cell 2021; 34: 977-989.","journal-title":"Hum Cell"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2174\/1389450122666210203192752","article-title":"Gamma secretase inhibitor: therapeutic target via NOTCH signaling in T cell acute lymphoblastic leukemia","volume":"22","author":"Kaushik","year":"2021","unstructured":"Kaushik B, Pal D and Saha S. Gamma secretase inhibitor: therapeutic target via NOTCH signaling in T cell acute lymphoblastic leukemia. Curr Drug Targets 2021; 22: 1789-1798.","journal-title":"Curr Drug Targets"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"101792","DOI":"10.1016\/j.jbc.2022.101792","article-title":"Verteporfin is a substrate-selective γ-secretase inhibitor that binds the amyloid precursor protein transmembrane domain","volume":"298","author":"Castro","year":"2022","unstructured":"Castro MA, Parson KF, Beg I, Wilkinson MC, Nurmakova K, Levesque I, Voehler MW, Wolfe MS, Ruotolo BT and Sanders CR. Verteporfin is a substrate-selective γ-secretase inhibitor that binds the amyloid precursor protein transmembrane domain. J Biol Chem 2022; 298: 101792.","journal-title":"J Biol Chem"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1158\/0008-5472.CAN-17-2808","article-title":"The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma","volume":"78","author":"Qiu","year":"2018","unstructured":"Qiu M, Xia W, Chen R, Wang S, Xu Y, Ma Z, Xu W, Zhang E, Wang J, Fang T, Hu J, Dong G, Yin R, Wang J and Xu L. The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res 2018; 78: 2839-2851.","journal-title":"Cancer Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CM9.0000000000002844","article-title":"Prognostic and clinical value of circPRKCI expression in diverse human cancers","volume":"137","author":"Liu","year":"2024","unstructured":"Liu Z, Ren X, Yang Z, Mei L, Li W, Tu C and Li Z. Prognostic and clinical value of circPRKCI expression in diverse human cancers. Chin Med J (Engl) 2024; 137: 152-161.","journal-title":"Chin Med J (Engl)"},{"key":"ref80","unstructured":"Sui MH, Zhang WW, Geng DM and Sun DJ. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D. Eur Rev Med Pharmacol Sci 2021; 25: 1899-1909."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41420-022-00892-y","article-title":"EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K\/AKT signaling pathway","volume":"8","author":"Wang","year":"2022","unstructured":"Wang X, Song H, Fang L and Wu T. EIF4A3-mediated circPRKCI expression promotes triple-negative breast cancer progression by regulating WBP2 and PI3K\/AKT signaling pathway. Cell Death Discov 2022; 8: 92.","journal-title":"Cell Death Discov"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.18632\/aging.203647","article-title":"Circular RNA circPRKCI contributes to malignant progression of T-cell acute lymphoblastic leukemia by modulating miR-20a-5p\/SOX4 axis","volume":"13","author":"Zheng","year":"2021","unstructured":"Zheng Y, Niu B, Zhang W, Ru X, Gao Y, Li C and Wu X. Circular RNA circPRKCI contributes to malignant progression of T-cell acute lymphoblastic leukemia by modulating miR-20a-5p\/SOX4 axis. Aging (Albany NY) 2021; 13: 23757-23768.","journal-title":"Aging (Albany NY)"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.2147\/OTT.S253468","article-title":"Circ-PRKDC contributes to 5-fluorouracil resistance of colorectal cancer cells by regulating miR-375\/FOXM1 axis and Wnt\/β-catenin pathway","volume":"13","author":"Chen","year":"2020","unstructured":"Chen H, Pei L, Xie P and Guo G. Circ-PRKDC contributes to 5-fluorouracil resistance of colorectal cancer cells by regulating miR-375\/FOXM1 axis and Wnt\/β-catenin pathway. Onco Targets Ther 2020; 13: 5939-5953.","journal-title":"Onco Targets Ther"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"12853","DOI":"10.2147\/CMAR.S273484","article-title":"Circ-PRKDC facilitates the progression of colorectal cancer through miR-198\/DDR1 regulatory axis","volume":"12","author":"Wang","year":"2020","unstructured":"Wang G, Li Y, Zhu H, Huo G, Bai J and Gao Z. Circ-PRKDC facilitates the progression of colorectal cancer through miR-198\/DDR1 regulatory axis. Cancer Manag Res 2020; 12: 12853-12865.","journal-title":"Cancer Manag Res"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/kjm2.12352","article-title":"The depletion of circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p\/Reelin mediation of the PI3K\/AKT\/mTOR signaling pathway","volume":"37","author":"Ling","year":"2021","unstructured":"Ling Z, Fang ZG, Wu JY and Liu JJ. The depletion of circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p\/Reelin mediation of the PI3K\/AKT\/mTOR signaling pathway. Kaohsiung J Med Sci 2021; 37: 392-401.","journal-title":"Kaohsiung J Med Sci"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore KP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenauer JC, Evans WE, Pui CH, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR and Mullighan CG. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157-163.","journal-title":"Nature"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","article-title":"Targeting PI3K\/AKT\/mTOR network for treatment of leukemia","volume":"72","author":"Bertacchini","year":"2015","unstructured":"Bertacchini J, Heidari N, Mediani L, Capitani S, Shahjahani M, Ahmadzadeh A and Saki N. Targeting PI3K\/AKT\/mTOR network for treatment of leukemia. Cell Mol Life Sci 2015; 72: 2337-2347.","journal-title":"Cell Mol Life Sci"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1007\/s12033-023-00830-y","article-title":"Bibliometric analysis of global research on circular RNA: current status and future directions","volume":"66","author":"Yehui","year":"2024","unstructured":"Yehui L, Zhihong L, Fang T, Zixuan Z, Mengyuan Z, Zhifang Y and Jiuhong Z. Bibliometric analysis of global research on circular RNA: current status and future directions. Mol Biotechnol 2024; 66: 2064-2077.","journal-title":"Mol Biotechnol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12943-022-01659-w","article-title":"Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP\/c-Myc\/SRSF1 positive feedback loop","volume":"21","author":"Mo","year":"2022","unstructured":"Mo Y, Wang Y, Wang Y, Deng X, Yan Q, Fan C, Zhang S, Zhang S, Gong Z, Shi L, Liao Q, Guo C, Li Y, Li G, Zeng Z, Jiang W, Xiong W and Xiang B. Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP\/c-Myc\/SRSF1 positive feedback loop. Mol Cancer 2022; 21: 192.","journal-title":"Mol Cancer"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Liu YY, Zhang LY and Du WZ. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p. Biosci Rep 2019; 39: BSR20193045.","DOI":"10.1042\/BSR20193045"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/cas.14814","article-title":"CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression","volume":"112","author":"Zheng","year":"2021","unstructured":"Zheng Z, Chen Z, Zhong Q, Zhu D, Xie Y, Shangguan W and Xie W. CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR-145-5p and regulating TBX15 expression. Cancer Sci 2021; 112: 1443-1456.","journal-title":"Cancer Sci"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2217\/epi-2017-0142","article-title":"Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia","volume":"10","author":"Hu","year":"2018","unstructured":"Hu J, Han Q, Gu Y, Ma J, McGrath M, Qiao F, Chen B, Song C and Ge Z. Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia. Epigenomics 2018; 10: 723-732.","journal-title":"Epigenomics"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/jcp.21133","article-title":"The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells","volume":"213","author":"Carramusa","year":"2007","unstructured":"Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A and Feo S. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol 2007; 213: 511-518.","journal-title":"J Cell Physiol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"153536","DOI":"10.1016\/j.prp.2021.153536","article-title":"Up-regulation of circPVT1 in T cell acute lymphoblastic leukemia promoted cell proliferation via miR-30e\/DLL4 induced activating NOTCH signaling","volume":"224","author":"Jia","year":"2021","unstructured":"Jia Y and Gu W. Up-regulation of circPVT1 in T cell acute lymphoblastic leukemia promoted cell proliferation via miR-30e\/DLL4 induced activating NOTCH signaling. Pathol Res Pract 2021; 224: 153536.","journal-title":"Pathol Res Pract"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/16078454.2021.1997197","article-title":"Circ_0000745 regulates NOTCH1-mediated cell proliferation and apoptosis in pediatric T-cell acute lymphoblastic leukemia through adsorbing miR-193b-3p","volume":"26","author":"Feng","year":"2021","unstructured":"Feng H, Li F and Tang P. Circ_0000745 regulates NOTCH1-mediated cell proliferation and apoptosis in pediatric T-cell acute lymphoblastic leukemia through adsorbing miR-193b-3p. Hematology 2021; 26: 885-895.","journal-title":"Hematology"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","article-title":"Deficient T cell fate specification in mice with an induced inactivation of Notch1","volume":"10","author":"Radtke","year":"1999","unstructured":"Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, MacDonald HR and Aguet M. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 1999; 10: 547-558.","journal-title":"Immunity"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1182\/blood-2008-03-147967","article-title":"Notch signaling mediates G1\/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases","volume":"113","author":"Joshi","year":"2009","unstructured":"Joshi I, Minter LM, Telfer J, Demarest RM, Capobianco AJ, Aster JC, Sicinski P, Fauq A, Golde TE and Osborne BA. Notch signaling mediates G1\/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases. Blood 2009; 113: 1689-1698.","journal-title":"Blood"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"181","DOI":"10.14715\/cmb\/2023.69.12.29","article-title":"CircBCAR3 sponges miR-27a-3p and mediates ferroptosis in human B-prolymphocytic leukaemia cells via SLC7A11","volume":"69","author":"Zhao","year":"2023","unstructured":"Zhao G, Chen H and Luo J. CircBCAR3 sponges miR-27a-3p and mediates ferroptosis in human B-prolymphocytic leukaemia cells via SLC7A11. Cell Mol Biol (Noisy-le-grand) 2023; 69: 181-187.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R and Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res 2021; 31: 107-125.","journal-title":"Cell Res"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR and Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 2021; 22: 266-282.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/ajh.24826","article-title":"Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment","volume":"92","author":"Hallek","year":"2017","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am J Hematol 2017; 92: 946-965.","journal-title":"Am J Hematol"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Yang S, Gale RP, Shi H, Liu Y, Lai Y, Lu J and Huang X. Is there an epidemic of chronic lymphocytic leukaemia (CLL) in China? Leuk Res 2018; 73: 16-20.","DOI":"10.1016\/j.leukres.2018.08.011"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-020-00170-6","article-title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","volume":"9","author":"Dong","year":"2020","unstructured":"Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y and Wang Q. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol 2020; 9: 14.","journal-title":"Exp Hematol Oncol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating M, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O’Brien S, Robak T, Seymour JF and Kipps TJ. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 2018; 131: 2745-2760.","journal-title":"Blood"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","unstructured":"Hallek M and Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol 2021; 96: 1679-1705.","journal-title":"Am J Hematol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.18632\/aging.101997","article-title":"Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p\/PML axis","volume":"11","author":"Wu","year":"2019","unstructured":"Wu W, Wu Z, Xia Y, Qin S, Li Y, Wu J, Liang J, Wang L, Zhu H, Fan L, Fu J, Xu W, Jin H and Li J. Downregulation of circ_0132266 in chronic lymphocytic leukemia promoted cell viability through miR-337-3p\/PML axis. Aging (Albany NY) 2019; 11: 3561-3573.","journal-title":"Aging (Albany NY)"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1387\/ijdb.210154av","article-title":"Promyelocytic leukemia protein (PML) and stem cells: from cancer to pluripotency","volume":"66","author":"Vogiatzoglou","year":"2022","unstructured":"Vogiatzoglou AP, Moretto F, Makkou M, Papamatheakis J and Kretsovali A. Promyelocytic leukemia protein (PML) and stem cells: from cancer to pluripotency. Int J Dev Biol 2022; 66: 85-95.","journal-title":"Int J Dev Biol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2018.06.045","article-title":"Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607\/FZD3\/Wnt\/β-catenin pathway","volume":"503","author":"Xia","year":"2018","unstructured":"Xia L, Wu L, Bao J, Li Q, Chen X, Xia H and Xia R. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607\/FZD3\/Wnt\/β-catenin pathway. Biochem Biophys Res Commun 2018; 503: 385-390.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.bbrc.2017.07.057","article-title":"Deregulation of WNT2\/FZD3\/β-catenin pathway compromises the estrogen synthesis in cumulus cells from patients with polycystic ovary syndrome","volume":"493","author":"Qiao","year":"2017","unstructured":"Qiao GY, Dong BW, Zhu CJ, Yan CY and Chen BL. Deregulation of WNT2\/FZD3\/β-catenin pathway compromises the estrogen synthesis in cumulus cells from patients with polycystic ovary syndrome. Biochem Biophys Res Commun 2017; 493: 847-854.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","article-title":"High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia","volume":"19","author":"Heintel","year":"2005","unstructured":"Heintel D, Kienle D, Shehata M, Kröber A, Kroemer E, Schwarzinger I, Mitteregger D, Le T, Gleiss A, Mannhalter C, Chott A, Schwarzmeier J, Fonatsch C, Gaiger A, Döhner H, Stilgenbauer S and Jäger U; CLL Study Group. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216-1223.","journal-title":"Leukemia"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40164-022-00302-0","article-title":"CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p\/LPL axis","volume":"11","author":"Wu","year":"2022","unstructured":"Wu Z, Gu D, Wang R, Zuo X, Zhu H, Wang L, Lu X, Xia Y, Qin S, Zhang W, Xu W, Fan L, Li J and Jin H. CircRIC8B regulates the lipid metabolism of chronic lymphocytic leukemia through miR199b-5p\/LPL axis. Exp Hematol Oncol 2022; 11: 51.","journal-title":"Exp Hematol Oncol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"2855394","DOI":"10.1155\/2022\/2855394","article-title":"circZNF91 promotes the malignant phenotype of chronic lymphocytic leukemia cells by targeting the miR-1283\/WEE1 axis","volume":"2022","author":"Li","year":"2022","unstructured":"Li S, Chen J, Fan Y, Xu X, Xiong M, Qi Y, Wu W and Zhao Y. circZNF91 promotes the malignant phenotype of chronic lymphocytic leukemia cells by targeting the miR-1283\/WEE1 axis. Biomed Res Int 2022; 2022: 2855394.","journal-title":"Biomed Res Int"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-020-00959-2","article-title":"A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target","volume":"13","author":"Luserna di Ror&#xE0","year":"2020","unstructured":"Ghelli Luserna di Rorà A, Cerchione C, Martinelli G and Simonetti G. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target. J Hematol Oncol 2020; 13: 126.","journal-title":"J Hematol Oncol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fonc.2019.01198","article-title":"Incidence and mortality trends and risk prediction nomogram for extranodal diffuse large B-cell lymphoma: an analysis of the surveillance, epidemiology, and end results database","volume":"9","author":"Yin","year":"2019","unstructured":"Yin X, Xu A, Fan F, Huang Z, Cheng Q, Zhang L, Sun C and Hu Y. Incidence and mortality trends and risk prediction nomogram for extranodal diffuse large B-cell lymphoma: an analysis of the surveillance, epidemiology, and end results database. Front Oncol 2019; 9: 1198.","journal-title":"Front Oncol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","unstructured":"Li S, Young KH and Medeiros LJ. Diffuse large B-cell lymphoma. Pathology 2018; 50: 74-87.","journal-title":"Pathology"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3892\/ol.2020.11374","article-title":"Expression of Foxp3 and interleukin-7 receptor and clinicopathological characteristics of patients with diffuse large B-cell lymphoma","volume":"19","author":"Zhao","year":"2020","unstructured":"Zhao Y, Cui WL, Feng ZY, Xue J, Gulinaer A and Zhang W. Expression of Foxp3 and interleukin-7 receptor and clinicopathological characteristics of patients with diffuse large B-cell lymphoma. Oncol Lett 2020; 19: 2755-2764.","journal-title":"Oncol Lett"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/0973-1482.183559","article-title":"Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: a single center study","volume":"14","author":"Lang","year":"2018","unstructured":"Lang J, Ma K, Guo J, Zhang J, Wang Q and Sun H. Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: a single center study. J Cancer Res Ther 2018; 14: 213-219.","journal-title":"J Cancer Res Ther"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"8068","DOI":"10.18632\/aging.102122","article-title":"A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt\/β-catenin signaling via interacting with TET1 and miR-888","volume":"11","author":"Hu","year":"2019","unstructured":"Hu Y, Zhao Y, Shi C, Ren P, Wei B, Guo Y and Ma J. A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt\/β-catenin signaling via interacting with TET1 and miR-888. Aging (Albany NY) 2019; 11: 8068-8084.","journal-title":"Aging (Albany NY)"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ceb.2007.02.007","article-title":"Wnt\/beta-catenin signaling in cancer stemness and malignant behavior","volume":"19","author":"Fodde","year":"2007","unstructured":"Fodde R and Brabletz T. Wnt\/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19: 150-158.","journal-title":"Curr Opin Cell Biol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"9351","DOI":"10.2147\/CMAR.S263222","article-title":"CircCFL1\/MiR-107 axis targeting HMGB1 promotes the malignant progression of diffuse large B-cell lymphoma tumors","volume":"12","author":"Chen","year":"2020","unstructured":"Chen X, Xie X and Zhou W. CircCFL1\/MiR-107 axis targeting HMGB1 promotes the malignant progression of diffuse large B-cell lymphoma tumors. Cancer Manag Res 2020; 12: 9351-9362.","journal-title":"Cancer Manag Res"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1038\/onc.2010.261","article-title":"HMGB1 release and redox regulates autophagy and apoptosis in cancer cells","volume":"29","author":"Tang","year":"2010","unstructured":"Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ and Lotze MT. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010; 29: 5299-5310.","journal-title":"Oncogene"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in inflammation and cancer","volume":"28","author":"Sims","year":"2010","unstructured":"Sims GP, Rowe DC, Rietdijk ST, Herbst R and Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28: 367-388.","journal-title":"Annu Rev Immunol"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s13258-021-01094-z","article-title":"CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p","volume":"43","author":"Liu","year":"2021","unstructured":"Liu W, Lei L, Liu X and Ye S. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p. Genes Genomics 2021; 43: 653-667.","journal-title":"Genes Genomics"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/10428194.2016.1228932","article-title":"The significance of FOXP1 in diffuse large B-cell lymphoma","volume":"58","author":"Gascoyne","year":"2017","unstructured":"Gascoyne DM and Banham AH. The significance of FOXP1 in diffuse large B-cell lymphoma. Leuk Lymphoma 2017; 58: 1037-1051.","journal-title":"Leuk Lymphoma"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1517\/14728222.11.7.955","article-title":"FOXP1: a potential therapeutic target in cancer","volume":"11","author":"Koon","year":"2007","unstructured":"Koon HB, Ippolito GC, Banham AH and Tucker PW. FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets 2007; 11: 955-965.","journal-title":"Expert Opin Ther Targets"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Walker MP, Stopford CM, Cederlund M, Fang F, Jahn C, Rabinowitz AD, Goldfarb D, Graham DM, Yan F, Deal AM, Fedoriw Y, Richards KL, Davis IJ, Weidinger G, Damania B and Major MB. FOXP1 potentiates Wnt\/β-catenin signaling in diffuse large B cell lymphoma. Sci Signal 2015; 8: ra12.","DOI":"10.1126\/scisignal.2005654"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"16824","DOI":"10.1002\/jcp.28358","article-title":"PD-1\/PD-L1 pathway: basic biology and role in cancer immunotherapy","volume":"234","author":"Salmaninejad","year":"2019","unstructured":"Salmaninejad A, Valilou SF, Shabgah AG, Aslani S, Alimardani M, Pasdar A and Sahebkar A. PD-1\/PD-L1 pathway: basic biology and role in cancer immunotherapy. J Cell Physiol 2019; 234: 16824-16837.","journal-title":"J Cell Physiol"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway","volume":"21","author":"Ohaegbulam","year":"2015","unstructured":"Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y and Zang X. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med 2015; 21: 24-33.","journal-title":"Trends Mol Med"},{"key":"ref129","unstructured":"Han Y, Liu D and Li L. PD-1\/PD-L1 pathway: current researches in cancer. Am J Cancer Res 2020; 10: 727-742."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood-2018-10-879015","article-title":"PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype","volume":"133","author":"Godfrey","year":"2019","unstructured":"Godfrey J, Tumuluru S, Bao R, Leukam M, Venkataraman G, Phillip J, Fitzpatrick C, McElherne J, MacNabb BW, Orlowski R, Smith SM and Kline J. PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype. Blood 2019; 133: 2279-2290.","journal-title":"Blood"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00277-014-2111-3","article-title":"Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients","volume":"93","author":"Song","year":"2014","unstructured":"Song G, Gu L, Li J, Tang Z, Liu H, Chen B, Sun X, He B, Pan Y, Wang S and Cho WC. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. Ann Hematol 2014; 93: 1735-1743.","journal-title":"Ann Hematol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1111\/cas.15402","article-title":"CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a\/b to disinhibit PD-L1","volume":"113","author":"Dong","year":"2022","unstructured":"Dong L, Huang J, Gao X, Du J, Wang Y and Zhao L. CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a\/b to disinhibit PD-L1. Cancer Sci 2022; 113: 2888-2903.","journal-title":"Cancer Sci"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","article-title":"Identification of virus-encoded microRNAs","volume":"304","author":"Pfeffer","year":"2004","unstructured":"Pfeffer S, Zavolan M, Grässer FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C and Tuschl T. Identification of virus-encoded microRNAs. Science 2004; 304: 734-736.","journal-title":"Science"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1261\/rna.2326106","article-title":"A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses","volume":"12","author":"Grundhoff","year":"2006","unstructured":"Grundhoff A, Sullivan CS and Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006; 12: 733-750.","journal-title":"RNA"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2020.11.019","article-title":"Epstein-Barr virus microRNAs in the pathogenesis of human cancers","volume":"499","author":"BFR","year":"2021","unstructured":"Caetano BFR, Jorge BAS, Müller-Coan BG and Elgui de Oliveira D. Epstein-Barr virus microRNAs in the pathogenesis of human cancers. Cancer Lett 2021; 499: 14-23.","journal-title":"Cancer Lett"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-021-01458-9","article-title":"CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p\/APC\/β-catenin axis","volume":"20","author":"Zhao","year":"2021","unstructured":"Zhao CX, Yan ZX, Wen JJ, Fu D, Xu PP, Wang L, Cheng S, Hu JD and Zhao WL. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p\/APC\/β-catenin axis. Mol Cancer 2021; 20: 153.","journal-title":"Mol Cancer"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle cell lymphoma","volume":"34","author":"CY","year":"2016","unstructured":"Cheah CY, Seymour JF and Wang ML. Mantle cell lymphoma. J Clin Oncol 2016; 34: 1256-1269.","journal-title":"J Clin Oncol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","unstructured":"Jain P and Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol 2019; 94: 710-725.","journal-title":"Am J Hematol"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/ajh.24797","article-title":"Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management","volume":"92","author":"Vose","year":"2017","unstructured":"Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management. Am J Hematol 2017; 92: 806-813.","journal-title":"Am J Hematol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1159\/000492665","article-title":"Mantle cell lymphoma case report","volume":"11","author":"Podzolkov","year":"2018","unstructured":"Podzolkov VI, Vargina TS, Pokrovskaya AE, Safronova TA and Abramova AA. Mantle cell lymphoma case report. Case Rep Oncol 2018; 11: 814-821.","journal-title":"Case Rep Oncol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1200\/JCO.19.01294","article-title":"Treatment of older patients with mantle cell lymphoma (MCL): long-term follow-up of the randomized European MCL elderly trial","volume":"38","author":"Kluin-Nelemans","year":"2020","unstructured":"Kluin-Nelemans HC, Hoster E, Hermine O, Walewski J, Geisler CH, Trneny M, Stilgenbauer S, Kaiser F, Doorduijn JK, Salles G, Szymczyk M, Tilly H, Kanz L, Schmidt C, Feugier P, Thieblemont C, Zijlstra JM, Ribrag V, Klapper W, Pott C, Unterhalt M and Dreyling MH. Treatment of older patients with mantle cell lymphoma (MCL): long-term follow-up of the randomized European MCL elderly trial. J Clin Oncol 2020; 38: 248-256.","journal-title":"J Clin Oncol"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41374-018-0108-6","article-title":"Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies","volume":"98","author":"Dahl","year":"2018","unstructured":"Dahl M, Daugaard I, Andersen MS, Hansen TB, Grønbæk K, Kjems J and Kristensen LS. Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies. Lab Invest 2018; 98: 1657-1669.","journal-title":"Lab Invest"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/21691401.2019.1596941","article-title":"CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer","volume":"47","author":"Sun","year":"2019","unstructured":"Sun J, Zhang H, Tao D, Xie F, Liu F, Gu C, Wang M, Wang L, Jiang G, Wang Z and Xiao X. CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer. Artif Cells Nanomed Biotechnol 2019; 47: 1349-1356.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"10215","DOI":"10.2147\/CMAR.S232075","article-title":"CircCDYL serves as a new biomarker in mantle cell lymphoma and promotes cell proliferation","volume":"11","author":"Mei","year":"2019","unstructured":"Mei M, Wang Y, Wang Q, Liu Y, Song W and Zhang M. CircCDYL serves as a new biomarker in mantle cell lymphoma and promotes cell proliferation. Cancer Manag Res 2019; 11: 10215-10221.","journal-title":"Cancer Manag Res"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41419-020-02757-7","article-title":"Circular RNA circCTNNA1 promotes colorectal cancer progression by sponging miR-149-5p and regulating FOXM1 expression","volume":"11","author":"Chen","year":"2020","unstructured":"Chen P, Yao Y, Yang N, Gong L, Kong Y and Wu A. Circular RNA circCTNNA1 promotes colorectal cancer progression by sponging miR-149-5p and regulating FOXM1 expression. Cell Death Dis 2020; 11: 557.","journal-title":"Cell Death Dis"},{"key":"ref146","doi-asserted-by":"publisher","unstructured":"Lu C, Song C, Han Q and Jing X. CircCTNNA1 is upregulated in mantle cell lymphoma and predicts poor survival by sponging miR-34a to increase cell proliferation. Mediterr J Hematol Infect Dis 2022; 14: e2022047.","DOI":"10.4084\/MJHID.2022.047"},{"key":"ref147","doi-asserted-by":"publisher","unstructured":"Marques SC, Ranjbar B, Laursen MB, Falgreen S, Bilgrau AE, Bødker JS, Jørgensen LK, Primo MN, Schmitz A, Ettrup MS, Johnsen HE, Bøgsted M, Mikkelsen JG and Dybkær K. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma. Exp Hematol 2016; 44: 238-246.e232.","DOI":"10.1016\/j.exphem.2015.12.007"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"MJ","year":"2015","unstructured":"You MJ, Medeiros LJ and Hsi ED. T-lymphoblastic leukemia\/lymphoma. Am J Clin Pathol 2015; 144: 411-422.","journal-title":"Am J Clin Pathol"},{"key":"ref149","doi-asserted-by":"publisher","unstructured":"Chan JY, Lim JQ and Ong CK. Towards next generation biomarkers in Natural Killer\/T-cell lymphoma. Life (Basel) 2021; 11: 838.","DOI":"10.3390\/life11080838"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.critrevonc.2017.03.020","article-title":"Lymphoblastic lymphoma","volume":"113","author":"Cortelazzo","year":"2017","unstructured":"Cortelazzo S, Ferreri A, Hoelzer D and Ponzoni M. Lymphoblastic lymphoma. Crit Rev Oncol Hematol 2017; 113: 304-317.","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000146081","article-title":"Adult precursor T-lymphoblastic leukemia\/lymphoma with myeloid-associated antigen expression is associated with a lower complete remission rate following induction chemotherapy","volume":"120","author":"Al Khabori","year":"2008","unstructured":"Al Khabori M, Samiee S, Fung S, Xu W, Brandwein J, Patterson B, Brien W and Chang H. Adult precursor T-lymphoblastic leukemia\/lymphoma with myeloid-associated antigen expression is associated with a lower complete remission rate following induction chemotherapy. Acta Haematol 2008; 120: 5-10.","journal-title":"Acta Haematol"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.gene.2019.03.052","article-title":"Circ-LAMP1 promotes T-cell lymphoblastic lymphoma progression via acting as a ceRNA for miR-615-5p to regulate DDR2 expression","volume":"701","author":"Deng","year":"2019","unstructured":"Deng L, Liu G, Zheng C, Zhang L, Kang Y and Yang F. Circ-LAMP1 promotes T-cell lymphoblastic lymphoma progression via acting as a ceRNA for miR-615-5p to regulate DDR2 expression. Gene 2019; 701: 146-151.","journal-title":"Gene"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1080\/08977194.2017.1354859","article-title":"MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients","volume":"35","author":"Rahmoon","year":"2017","unstructured":"Rahmoon MA, Youness RA, Gomaa AI, Hamza MT, Waked I, El Tayebi HM and Abdelaziz AI. MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patients. Growth Factors 2017; 35: 76-87.","journal-title":"Growth Factors"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1007\/s13277-015-4506-8","article-title":"miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma","volume":"37","author":"Wu","year":"2016","unstructured":"Wu X, Deng L, Tang D, Ying G, Yao X, Liu F and Liang G. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma. Tumour Biol 2016; 37: 6813-6821.","journal-title":"Tumour Biol"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s13277-015-3900-6","article-title":"CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p","volume":"37","author":"Jiang","year":"2016","unstructured":"Jiang Y, Zhang Y, Li F, Du X and Zhang J. CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p. Tumour Biol 2016; 37: 1041-1049.","journal-title":"Tumour Biol"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.str.2009.10.012","article-title":"Crystallographic insight into collagen recognition by discoidin domain receptor 2","volume":"17","author":"Carafoli","year":"2009","unstructured":"Carafoli F, Bihan D, Stathopoulos S, Konitsiotis AD, Kvansakul M, Farndale RW, Leitinger B and Hohenester E. Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure 2009; 17: 1573-1581.","journal-title":"Structure"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"52","DOI":"10.20892\/j.issn.2095-3941.2020.0400","article-title":"Updating targets for natural killer\/T-cell lymphoma immunotherapy","volume":"18","author":"Xue","year":"2021","unstructured":"Xue W and Zhang M. Updating targets for natural killer\/T-cell lymphoma immunotherapy. Cancer Biol Med 2021; 18: 52-62.","journal-title":"Cancer Biol Med"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","article-title":"Molecular pathogenic pathways in extranodal NK\/T cell lymphoma","volume":"12","author":"de Mel","year":"2019","unstructured":"de Mel S, Hue SS, Jeyasekharan AD, Chng WJ and Ng SB. Molecular pathogenic pathways in extranodal NK\/T cell lymphoma. J Hematol Oncol 2019; 12: 33.","journal-title":"J Hematol Oncol"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12935-021-02296-x","article-title":"CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3","volume":"21","author":"Mei","year":"2021","unstructured":"Mei M, Wang Y, Song W, Li Z, Wang Q, Li J and Zhang M. CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3. Cancer Cell Int 2021; 21: 594.","journal-title":"Cancer Cell Int"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-019-0717-6","article-title":"Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)","volume":"12","author":"Somasundaram","year":"2019","unstructured":"Somasundaram N, Lim JQ, Ong CK and Lim ST. Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL). J Hematol Oncol 2019; 12: 28.","journal-title":"J Hematol Oncol"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/imt.15.103","article-title":"Novel targets for natural killer\/T-cell lymphoma immunotherapy","volume":"8","author":"Kumai","year":"2016","unstructured":"Kumai T, Kobayashi H and Harabuchi Y. Novel targets for natural killer\/T-cell lymphoma immunotherapy. Immunotherapy 2016; 8: 45-55.","journal-title":"Immunotherapy"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"16500","DOI":"10.18632\/aging.203172","article-title":"Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer","volume":"13","author":"Chen","year":"2021","unstructured":"Chen W, Fu J, Chen Y, Li Y, Ning L, Huang D, Yan S and Zhang Q. Circular RNA circKIF4A facilitates the malignant progression and suppresses ferroptosis by sponging miR-1231 and upregulating GPX4 in papillary thyroid cancer. Aging (Albany NY) 2021; 13: 16500-16512.","journal-title":"Aging (Albany NY)"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s10020-020-00159-1","article-title":"circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling","volume":"26","author":"Huo","year":"2020","unstructured":"Huo LW, Wang YF, Bai XB, Zheng HL and Wang MD. circKIF4A promotes tumorogenesis of glioma by targeting miR-139-3p to activate Wnt5a signaling. Mol Med 2020; 26: 29.","journal-title":"Mol Med"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12943-019-0946-x","article-title":"circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer","volume":"18","author":"Tang","year":"2019","unstructured":"Tang H, Huang X, Wang J, Yang L, Kong Y, Gao G, Zhang L, Chen ZS and Xie X. circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer. Mol Cancer 2019; 18: 23.","journal-title":"Mol Cancer"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.18632\/aging.204276","article-title":"CircKIF4A promotes non-small cell lung cancer proliferation and metastasis through MiR-1238\/CLDN14 axis","volume":"14","author":"Luo","year":"2022","unstructured":"Luo W, Liu Y, Qu H, Luo X, Xu L, Zhang J and Wang J. CircKIF4A promotes non-small cell lung cancer proliferation and metastasis through MiR-1238\/CLDN14 axis. Aging (Albany NY) 2022; 14: 7408-7415.","journal-title":"Aging (Albany NY)"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.3390\/cancers14194950","article-title":"CircKIF4A is a prognostic factor and modulator of Natural Killer\/T-cell lymphoma progression","volume":"14","author":"He","year":"2022","unstructured":"He R, Wen W, Fu B, Zhu R, Chen G, Bai S, Cao X and Wang H. CircKIF4A is a prognostic factor and modulator of Natural Killer\/T-cell lymphoma progression. Cancers (Basel) 2022; 14: 4950.","journal-title":"Cancers (Basel)"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/08916934.2021.2023863","article-title":"Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB","volume":"55","author":"Lin","year":"2022","unstructured":"Lin D, Wang Y, Lei L and Lin C. Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB. Autoimmunity 2022; 55: 127-135.","journal-title":"Autoimmunity"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/CAD.0000000000001366","article-title":"Hsa_circ_0000877 facilitates the progression of diffuse large B-cell lymphoma by miR-370-3p\/mitogen-activated protein kinase kinase kinase kinase 4\/Hippo pathway","volume":"33","author":"Zhan","year":"2022","unstructured":"Zhan C, Zhou H, Zhang W and Si C. Hsa_circ_0000877 facilitates the progression of diffuse large B-cell lymphoma by miR-370-3p\/mitogen-activated protein kinase kinase kinase kinase 4\/Hippo pathway. Anticancer Drugs 2022; 33: 1091-1102.","journal-title":"Anticancer Drugs"},{"key":"ref169","unstructured":"Yang CS, Lou Y, Ke QP, Xu XJ and Zhang Y. Mechanism of circZNF609 targeting miR-153 to regulate the proliferation and apoptosis of diffuse large B-cell lymphoma. Zhonghua Zhong Liu Za Zhi 2022; 44: 238-245."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/15384101.2021.1897272","article-title":"NRF1-regulated circNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1","volume":"20","author":"Wang","year":"2021","unstructured":"Wang L, Yang B, Xu Z, Song X, Gong Z, Xue S and Kong L. NRF1-regulated circNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1. Cell Cycle 2021; 20: 819-828.","journal-title":"Cell Cycle"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0157582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:40Z","timestamp":1766023000000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/9\/ajcr0157582.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":171,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/kmwb5164","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}